<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02439021</url>
  </required_header>
  <id_info>
    <org_study_id>653</org_study_id>
    <nct_id>NCT02439021</nct_id>
  </id_info>
  <brief_title>Effectiveness of the New Perilaryngeal Airway in Comparison With the Laryngeal Mask Airway</brief_title>
  <official_title>Effectiveness of the New Perilaryngeal Airway (CobraPLA™) in Comparison With the Laryngeal Mask Airway (LMA™) to Improve Oropharyngeal Leak Pressure Among Obese and Overweight Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Qazvin University Of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Qazvin University Of Medical Sciences</source>
  <brief_summary>
    <textblock>
      The Laryngeal Mask Airway (LMA) has been used widely for different patients and found to be
      highly safe for adult and pediatric patients. However, the LMA has some limitations and
      weaknesses (e.g. more insertion attempts in 5% to 10 % of all cases. Despite the easy
      insertion of the LMA, it is crucial to check correct placement of the LMA airway.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oropharyngeal leak</measure>
    <time_frame>Up to 1 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to intubation</measure>
    <time_frame>Up to 1 hours</time_frame>
    <description>Time to intubation was measured from inserting of the device to the patient's month while connecting the breathing circuit</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>successful intubation attempt</measure>
    <time_frame>Up to 1 hours</time_frame>
    <description>A successful intubation attempt was recognized if: the breathing circuit connected, the EtCO2 trace was revealed, and no air leak was detected at airway pressures of 15 cm H2O</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of sore throat</measure>
    <time_frame>Up to 1 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of dysphasia</measure>
    <time_frame>Up to 1 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of postoperative blood staining on mask</measure>
    <time_frame>Up to 1 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">74</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>CobraPLA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will randomly assign to either LMA or Cobra PLATM</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LMA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will randomly assign to either LMA or Cobra PLATM</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>COBRA</intervention_name>
    <arm_group_label>CobraPLA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LMA</intervention_name>
    <arm_group_label>LMA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI between 25 to 35 kg/m2

          -  scheduled for surgery

          -  being older than 18 years

          -  Mallampati class I-III and BMI between 25 and 35

        Exclusion Criteria:

          -  pregnancy

          -  morbid obese (BMI&gt;35 kg/m2)

          -  a known difficult airway

          -  gastro‐oesophageal reflux

          -  pharyngeal pathology

          -  emergency operation with full stomach
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amir H Pakpour, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Qazvin University Of Medical Sciences</affiliation>
  </overall_official>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 5, 2015</study_first_submitted>
  <study_first_submitted_qc>May 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 8, 2015</study_first_posted>
  <last_update_submitted>May 5, 2015</last_update_submitted>
  <last_update_submitted_qc>May 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Qazvin University Of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Amir H Pakpour</investigator_full_name>
    <investigator_title>Assistant Professor, Department of Public Health, Qazvin University of Medical Sciences, Qazvin, Iran.</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

